Načítá se...

De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis

AIM: To compare efficacy of combined lamivudine (LAM) and adefovir dipivoxil (ADV) therapy with that of entecavir (ETV) monotherapy for hepatitis B virus (HBV)-related decompensated liver cirrhosis. METHODS: A total of 120 naïve patients with HBV-related decompensated cirrhosis participated in this...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Lian, Jiang-Shan, Zeng, Lin-Yan, Chen, Jian-Yang, Jia, Hong-Yu, Zhang, Yi-Min, Xiang, Dai-Rong, Yu, Liang, Hu, Jian-Hua, Lu, Ying-Feng, Zheng, Ling, Li, Lan-Juan, Yang, Yi-Da
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Co., Limited 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3787360/
https://ncbi.nlm.nih.gov/pubmed/24115827
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v19.i37.6278
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!